View Press Releases
-
Creative Proteomics Launches Untargeted Metabolomics Services for Drug Development
SHIRLEY, NY, UNITED STATES - Jul 13, 2020 - Creative Proteomics, an integrated CRO company that provides a full range of drug development services, has recently launched its fully-developed untargeted metabolomics services to researchers
Jul 13, 2020
-
CD Genomics Announces MicroCollect™ FDA&CE Certificated Virus Collection Swab Kits for SARS-CoV-2 Detection
SHIRLEY, NY, UNITED STATES - Jul 13, 2020 - CD Genomics, an internationally leading provider of microbial testing services, microbial genomics services, and integrated bioinformatics services for hospitals, food, diagnostics, pharma, agriculture, biotechnology, and research institutes, announces advanced virus collection kit for SARS-CoV-2 detection
Jul 13, 2020
-
Creative Enzymes Optimizes Enzyme Stabilization and Formulation Services
SHIRLEY, NY, UNITED STATES - Jul 13, 2020 - As an excellent supplier and manufacturer, Creative Enzymes has recently optimized enzyme stabilization and formulation services for researchers working in the life science field
Jul 13, 2020
-
Wearable, Wireless Biometric Sensor Devices from Shimmer Provide Much-Needed Patient Data in Battle Against COVID-19
CAMBRIDGE, MA, UNITED STATES - Jul 9, 2020 - Shimmer, a leading provider of wearable wireless sensor products and solutions, has partnered with the University of South Florida to develop an early warning system, including a wearable device, to help detect the progression of COVID-19 for those most at risk of severe infection
Jul 9, 2020
-
TrialScope Expands Leadership Team with New Chief Commercial Officer
JERSEY CITY, NJ, UNITED STATES - Jul 9, 2020 - TrialScope, the global leader in clinical trial transparency, has hired Chris Venezia as Chief Commercial Officer, expanding its executive team
Jul 9, 2020
-
HENRY SCHEIN MEDICAL ANNOUNCES EXPANSION OF MEDPOD’S TELEMEDICINE SOLUTIONS WITH INTEGRATION OF VISUALDX
MELVILLE, NY, UNITED STATES - Jul 9, 2020 - Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. and exclusive distributor of Medpod, Inc
Jul 9, 2020
-
SCL Health Partners with Kyruus to Enhance Consumer and Provider Experience
BOSTON, MA, UNITED STATES - Jul 8, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, and SCL Health, a faith-based nonprofit health system providing care across Colorado, Kansas, and Montana, today announced that SCL Health has selected Kyruus patient access and provider data management platform to enable its digital access initiatives
Jul 8, 2020
-
Absolute Antibody and University of Zurich Collaborate to Offer Synthetic Nanobodies Against SARS-CoV-2 Receptor Binding Domain
REDCAR, UNITED KINGDOM - Jul 8, 2020 - Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced a partnership with University of Zurich to offer synthetic nanobodies against the receptor binding domain (RBD) of SARS-CoV-2, the coronavirus that causes COVID-19
Jul 8, 2020
-
Optibrium and North Carolina School of Science and Mathematics mark five years of education collaboration with summer school ‘Computing COVID-19’
CAMBRIDGE, UK AND DURHAM, NC, USA, UNITED KINGDOM - Jul 8, 2020 - Optibrium, a leading provider of software and services for drug discovery, and the North Carolina School of Science and Mathematics (NCSSM), the states leading high school for science, technology and math education, are celebrating five years of an education support collaboration
Jul 8, 2020
-
Boehringer Ingelheim Extends TrialScope Partnership
JERSEY CITY, NJ, UNITED STATES - Jul 7, 2020 - In its ongoing commitment to maintaining compliance with ever-changing global clinical trial disclosure regulations, Boehringer Ingelheim has renewed its partnership with TrialScope for an additional five years
Jul 7, 2020
-
InSysBio to announce the launch of its new tool Heta compiler
MOSCOW, RUSSIA - Jul 6, 2020 - InSysBio, one of the worlds pioneers of Quantitative Systems Pharmacology (QSP) modeling, presents Heta compiler which is a tool for the development of Quantitative Systems Pharmacology and Systems Biology platforms
Jul 7, 2020
-
OPTRONICS Releases New Visual Inspection Tools Now Available on GSA Contract.
GOLETA, CA, UNITED STATES - Jul 6, 2020 - FOR IMMEDIATE RELEASE
Jul 6, 2020
OPTRONICS Releases New Visual Inspection Tools Now Available on GSA Contract
-
Kyruus Obtains AVIA Recognition for Its Enterprise-Wide Patient Access Platform
BOSTON, MA, UNITED STATES - Jul 1, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, today announced that AVIA, the nation's leading digital transformation partner for healthcare organizations, has recognized its full suite of technology solutions with AVIA Vetted and/or Market Validated designations for 2020
Jul 1, 2020
-
Creative Diagnostics Expands Response to COVID-19 to Recombinant SARS-CoV-2 RBD Mutants
NEW YORK, NY, UNITED STATES - Jul 2, 2020 - As COVID-19 is still spreading all over the world, the global confirmed cases have jumped to 9 million
Jun 30, 2020
-
CD Bioparticles: A Trustworthy Provider of All Sorts of PEG Conjugations
SHIRLEY, NY, UNITED STATES - Jul 1, 2020 - Polyethylene glycol (PEG), a biocompatible, synthetic, hydrophilic polyether compound, is non-toxic, FDA-approved, and is frequently used in many biomedical applications including bioconjugation, drug delivery, surface functionalization, and tissue engineering
Jun 30, 2020
-
Creative Biolabs Updated Exosome Isolation and Profiling Service to Facilitate Related Research
SHIRLEY, NY, UNITED STATES - Jul 1, 2020 - Recently, exosomes, which have specialized functions and play a key role in different physiological processes and pathological conditions, are attracting increasing attention in their clinical applications for prognosis, diagnosis, drug delivery, and vaccine development
Jun 30, 2020
-
Kyruus Achieves SOC 2 Type II Attestation
BOSTON, MA, UNITED STATES - Jun 29, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, today announced that it has successfully completed its System and Organization Controls (SOC) 2 Type II examination by an independent auditor
Jun 29, 2020
-
Genomics England launches next-generation research platform central to UK COVID-19 response
LONDON, UK - Jun 29, 2020 - Genomics England (GEL) has today launched a next-generation genomic research platform that will play a key role in the research response to COVID-19
Jun 29, 2020
-
AI & Medicine Releases Biomarker Discovery and Targeted Proteomics Services for Researchers
NY, NY, UNITED STATES - Jun 23, 2020 - As an expert in the field of AI-Powered drug discovery, personalized healthcare and various medical applications, the New York-based company AI & Medicine recently announces to release biomarker discovery and targeted proteomics services for researchers worldwide
Jun 29, 2020
-
Intermediates for API about Flu Treatment Are Now Available at Alfa Chemistry
NY, NY, UNITED STATES - Jun 24, 2020 - Earlier this year, Alfa Chemistry announced to have released a series of intermediates for API about flu treatment, including oseltamivir intermediates, zanamivir intermediates, and peramivir intermediates, for its valued customers both at home and abroad
Jun 29, 2020
